Literature DB >> 30870841

Clinical Profile and Ventricular Arrhythmias after Sacubitril/Valsartan Initiation.

Lourdes Vicent1, Miriam Juárez1, Vanesa Bruña1, Carolina Devesa1, Iago Sousa-Casasnovas1, Francisco Fernández-Avilés1,2, Manuel Martinez-Sellés3,4,5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30870841     DOI： 10.1159/000497190

Source DB:  PubMed          Journal:  Cardiology        ISSN： 0008-6312            Impact factor:   1.869


× No keyword cloud information.
  4 in total

Review 1.  A narrative review on sacubitril/valsartan and ventricular arrhythmias.

Authors:  Zhaoyang Wei; Meiwei Zhang; Qian Zhang; Linan Gong; Xiangyu Wang; Zanzan Wang; Ming Gao; Zhiguo Zhang
Journal:  Medicine (Baltimore)       Date:  2022-07-08       Impact factor: 1.817

2.  Exploration of Mechanisms of Sacubitril/Valsartan in the Treatment of Cardiac Arrhythmias Using a Network Pharmacology Approach.

Authors:  Yu Zhou; Shibao Rui; Shengxin Tang; Changlin Ju
Journal:  Front Cardiovasc Med       Date:  2022-04-13

3.  Sacubitrilat reduces pro-arrhythmogenic sarcoplasmic reticulum Ca2+ leak in human ventricular cardiomyocytes of patients with end-stage heart failure.

Authors:  Jörg Eiringhaus; Christoph M Wünsche; Petros Tirilomis; Jonas Herting; Nadja Bork; Viacheslav O Nikolaev; Gerd Hasenfuss; Samuel Sossalla; Thomas H Fischer
Journal:  ESC Heart Fail       Date:  2020-07-25

Review 4.  Sacubitril/Valsartan in the Management of Heart Failure Patients with Cardiac Implantable Electronic Devices.

Authors:  Sijing Cheng; Nixiao Zhang; Wei Hua
Journal:  Am J Cardiovasc Drugs       Date:  2020-10-28       Impact factor: 3.571
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.